811 related articles for article (PubMed ID: 34922977)
1. Patient pIgR-enriched extracellular vesicles drive cancer stemness, tumorigenesis and metastasis in hepatocellular carcinoma.
Tey SK; Wong SWK; Chan JYT; Mao X; Ng TH; Yeung CLS; Leung Z; Fung HL; Tang AHN; Wong DKH; Mak LY; Yuen MF; Sin CF; Ng IO; Ma SKY; Lee TKW; Cao P; Zhong K; Gao Y; Yun JP; Yam JWP
J Hepatol; 2022 Apr; 76(4):883-895. PubMed ID: 34922977
[TBL] [Abstract][Full Text] [Related]
2. Physical exercise suppresses hepatocellular carcinoma progression by alleviating hypoxia and attenuating cancer stemness through the Akt/GSK-3β/β-catenin pathway.
Xiao CL; Zhong ZP; Lü C; Guo BJ; Chen JJ; Zhao T; Yin ZF; Li B
J Integr Med; 2023 Mar; 21(2):184-193. PubMed ID: 36781361
[TBL] [Abstract][Full Text] [Related]
3. Extracellular vesicles-derived OncomiRs mediate communication between cancer cells and cancer-associated hepatic stellate cells in hepatocellular carcinoma microenvironment.
Li J; Yan Y; Ang L; Li X; Liu C; Sun B; Lin X; Peng Z; Zhang X; Zhang Q; Wu H; Zhao M; Su C
Carcinogenesis; 2020 Apr; 41(2):223-234. PubMed ID: 31140556
[TBL] [Abstract][Full Text] [Related]
4. Tumor cells derived-extracellular vesicles transfer miR-3129 to promote hepatocellular carcinoma metastasis by targeting TXNIP.
Yang Y; Mao F; Guo L; Shi J; Wu M; Cheng S; Guo W
Dig Liver Dis; 2021 Apr; 53(4):474-485. PubMed ID: 33563583
[TBL] [Abstract][Full Text] [Related]
5. Tumour extracellular vesicle-derived Complement Factor H promotes tumorigenesis and metastasis by inhibiting complement-dependent cytotoxicity of tumour cells.
Mao X; Zhou L; Tey SK; Ma APY; Yeung CLS; Ng TH; Wong SWK; Liu BHM; Fung YME; Patz EF; Cao P; Gao Y; Yam JWP
J Extracell Vesicles; 2020 Nov; 10(1):e12031. PubMed ID: 33708358
[TBL] [Abstract][Full Text] [Related]
6. Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma.
Toh TB; Lim JJ; Hooi L; Rashid MBMA; Chow EK
J Hepatol; 2020 Jan; 72(1):104-118. PubMed ID: 31541681
[TBL] [Abstract][Full Text] [Related]
7. Actin-related protein 2/3 complex subunit 2-enriched extracellular vesicles drive liver cancer metastasis.
Mei P; Tey SK; Wong SWK; Ng TH; Mao X; Yeung CLS; Xu Y; Yu L; Huang Q; Cao P; Yam JWP; Gao Y
Hepatol Int; 2022 Jun; 16(3):603-613. PubMed ID: 35556226
[TBL] [Abstract][Full Text] [Related]
8. FAM134B induces tumorigenesis and epithelial-to-mesenchymal transition via Akt signaling in hepatocellular carcinoma.
Zhang ZQ; Chen J; Huang WQ; Ning D; Liu QM; Wang C; Zhang L; Ren L; Chu L; Liang HF; Fan HN; Zhang BX; Chen XP
Mol Oncol; 2019 Apr; 13(4):792-810. PubMed ID: 30556279
[TBL] [Abstract][Full Text] [Related]
9. Silencing MYH9 blocks HBx-induced GSK3β ubiquitination and degradation to inhibit tumor stemness in hepatocellular carcinoma.
Lin X; Li AM; Li YH; Luo RC; Zou YJ; Liu YY; Liu C; Xie YY; Zuo S; Liu Z; Liu Z; Fang WY
Signal Transduct Target Ther; 2020 Feb; 5(1):13. PubMed ID: 32296025
[TBL] [Abstract][Full Text] [Related]
10. IL-3R-alpha blockade inhibits tumor endothelial cell-derived extracellular vesicle (EV)-mediated vessel formation by targeting the β-catenin pathway.
Lombardo G; Gili M; Grange C; Cavallari C; Dentelli P; Togliatto G; Taverna D; Camussi G; Brizzi MF
Oncogene; 2018 Mar; 37(9):1175-1191. PubMed ID: 29238040
[TBL] [Abstract][Full Text] [Related]
11. S100A10 promotes HCC development and progression via transfer in extracellular vesicles and regulating their protein cargos.
Wang X; Huang H; Sze KM; Wang J; Tian L; Lu J; Tsui YM; Ma HT; Lee E; Chen A; Lee J; Wang Y; Yam JWP; Cheung TT; Guan X; Ng IO
Gut; 2023 Jul; 72(7):1370-1384. PubMed ID: 36631249
[TBL] [Abstract][Full Text] [Related]
12. Polymeric immunoglobulin receptor promotes tumor growth in hepatocellular carcinoma.
Yue X; Ai J; Xu Y; Chen Y; Huang M; Yang X; Hu B; Zhang H; He C; Yang X; Tang W; Peng X; Dong L; Wang H; Fan J; Ding J; Geng M
Hepatology; 2017 Jun; 65(6):1948-1962. PubMed ID: 28073159
[TBL] [Abstract][Full Text] [Related]
13. TPI1-reduced extracellular vesicles mediated by Rab20 downregulation promotes aerobic glycolysis to drive hepatocarcinogenesis.
Liu BHM; Tey SK; Mao X; Ma APY; Yeung CLS; Wong SWK; Ng TH; Xu Y; Yao Y; Fung EYM; Tan KV; Khong PL; Ho DW; Ng IO; Tang AHN; Cai SH; Yun JP; Yam JWP
J Extracell Vesicles; 2021 Aug; 10(10):e12135. PubMed ID: 34401050
[TBL] [Abstract][Full Text] [Related]
14. Bone mesenchymal stem cells derived extracellular vesicles promote TRAIL-related apoptosis of hepatocellular carcinoma cells via the delivery of microRNA-20a-3p.
Deng L; Wang C; He C; Chen L
Cancer Biomark; 2021; 30(2):223-235. PubMed ID: 33136092
[TBL] [Abstract][Full Text] [Related]
15. The role of polymeric immunoglobulin receptor in inflammation-induced tumor metastasis of human hepatocellular carcinoma.
Ai J; Tang Q; Wu Y; Xu Y; Feng T; Zhou R; Chen Y; Gao X; Zhu Q; Yue X; Pan Q; Xu S; Li J; Huang M; Daugherty-Holtrop J; He Y; Xu HE; Fan J; Ding J; Geng M
J Natl Cancer Inst; 2011 Nov; 103(22):1696-712. PubMed ID: 22025622
[TBL] [Abstract][Full Text] [Related]
16. Tumor-derived extracellular vesicles containing long noncoding RNA PART1 exert oncogenic effect in hepatocellular carcinoma by polarizing macrophages into M2.
Zhou J; Che J; Xu L; Yang W; Zhou W; Zhou C
Dig Liver Dis; 2022 Apr; 54(4):543-553. PubMed ID: 34497040
[TBL] [Abstract][Full Text] [Related]
17. Secretory clusterin promotes hepatocellular carcinoma progression by facilitating cancer stem cell properties via AKT/GSK-3β/β-catenin axis.
Zheng W; Yao M; Wu M; Yang J; Yao D; Wang L
J Transl Med; 2020 Feb; 18(1):81. PubMed ID: 32059741
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-23b functions as an oncogene and activates AKT/GSK3β/β-catenin signaling by targeting ST7L in hepatocellular carcinoma.
Zhuang L; Wang X; Wang Z; Ma X; Han B; Zou H; Wu Z; Dong S; Qu Z; Zang Y; Wu L
Cell Death Dis; 2017 May; 8(5):e2804. PubMed ID: 28518144
[TBL] [Abstract][Full Text] [Related]
19. WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway.
Ni CX; Qi Y; Zhang J; Liu Y; Xu WH; Xu J; Hu HG; Wu QY; Wang Y; Zhang JP
Oncotarget; 2016 Nov; 7(48):79544-79556. PubMed ID: 27783993
[TBL] [Abstract][Full Text] [Related]
20. Polymeric immunoglobulin receptor (PIGR) exerts oncogenic functions via activating ribosome pathway in hepatocellular carcinoma.
Zhang Y; Zhang J; Chen X; Yang Z
Int J Med Sci; 2021; 18(2):364-371. PubMed ID: 33390805
[No Abstract] [Full Text] [Related]
[Next] [New Search]